Skip to main content

Gibney Anthony S

In the past year, 1 open-market sale filing worth $82.3K and no purchases.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
$82.3K
1 filing
Net
−$82.3K
Bought minus sold
Companies
1
With open-market trades

Trades

Every Form 4 that lists Gibney Anthony S as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

AURA Aura Biosciences, Inc.

See Remarks4 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jun 16, 2026 (view filing)Jun 16Same dayGibney Anthony SSee RemarksSSale−12.8K$6.42−$82.3K−4.6%265.4K after
May 20, 2025 (view filing)May 164 daysGibney Anthony SSee RemarksPPurchase+50.0K$4.90+$245.0K+591.6%58.5K after
May 20, 2025 (view filing)May 164 daysGibney Anthony SSee RemarksSSale−1.52K$5.15−$7.82K−2.6%56.9K after
May 20, 2025 (view filing)May 164 daysGibney Anthony SSee RemarksPPurchase+12.5K–––12.5K afterDerivative

CLSD Clearside Biomedical, Inc.

Director1 trade

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Apr 19, 2024 (view filing)Apr 17-182 daysGibney Anthony SDirectorPPurchase+100.0K$1.30+$129.7KNew position100.0K after2 lots

ISEE IVERIC bio, Inc.

EVP, Chief Business Officer1 trade

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jul 5, 2022 (view filing)Jul 5Same dayGibney Anthony SEVP, Chief Business OfficerSSale−7.79K$9.41−$73.3K−41.6%11.0K after